Literature DB >> 33467126

Epidemiology of Anthropometric Factors in Glioblastoma Multiforme-Literature Review.

Donata Simińska1, Jan Korbecki1, Klaudyna Kojder2, Patrycja Kapczuk1, Marta Fabiańska3, Izabela Gutowska4, Anna Machoy-Mokrzyńska5, Dariusz Chlubek1, Irena Baranowska-Bosiacka1.   

Abstract

Although glioblastoma multiforme (GBM) is a widely researched cancer of the central nervous system, we still do not know its full pathophysiological mechanism and we still lack effective treatment methods as the current combination of surgery, radiotherapy, and chemotherapy does not bring about satisfactory results. The median survival time for GBM patients is only about 15 months. In this paper, we present the epidemiology of central nervous system (CNS) tumors and review the epidemiological data on GBM regarding gender, age, weight, height, and tumor location. The data indicate the possible influence of some anthropometric factors on the occurrence of GBM, especially in those who are male, elderly, overweight, and/or are taller. However, this review of single and small-size epidemiological studies should not be treated as definitive due to differences in the survey methods used. Detailed epidemiological registers could help identify the main at-risk groups which could then be used as homogenous study groups in research worldwide. Such research, with less distortion from various factors, could help identify the pathomechanisms that lead to the development of GBM.

Entities:  

Keywords:  age; epidemiology; gender; glioblastoma multiforme; height; obesity; overweight; sex

Year:  2021        PMID: 33467126      PMCID: PMC7829953          DOI: 10.3390/brainsci11010116

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  85 in total

Review 1.  Growth Hormone's Links to Cancer.

Authors:  Cesar Luiz Boguszewski; Margaret Cristina da Silva Boguszewski
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

2.  Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions.

Authors:  Song Tao Timothy Cheo; Gek Hsiang Lim; Keith Hsiu Chin Lim
Journal:  Singapore Med J       Date:  2016-02-26       Impact factor: 1.858

Review 3.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

Review 4.  Height and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies.

Authors:  Dagfinn Aune; Ana Rita Vieira; Doris Sau Man Chan; Deborah A Navarro Rosenblatt; Rui Vieira; Darren C Greenwood; Janet E Cade; Victoria J Burley; Teresa Norat
Journal:  Cancer Causes Control       Date:  2012-06-12       Impact factor: 2.506

5.  Ten-year review of survival and management of malignant glioma in Hong Kong.

Authors:  D Tm Chan; S Yp Hsieh; C Ky Lau; M Km Kam; H Hf Loong; W K Tsang; D Mc Poon; W S Poon
Journal:  Hong Kong Med J       Date:  2016-12-02       Impact factor: 2.227

Review 6.  Sex- and gender-specific disparities in colorectal cancer risk.

Authors:  Sung-Eun Kim; Hee Young Paik; Hyuk Yoon; Jung Eun Lee; Nayoung Kim; Mi-Kyung Sung
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 7.  Human Aging and Cancer: Role of miRNA in Tumor Microenvironment.

Authors:  Oleta A Sandiford; Caitlyn A Moore; Jun Du; Mathieu Boulad; Marina Gergues; Hussam Eltouky; Pranela Rameshwar
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 8.  Adolescent and Young Adult Cancer Biology.

Authors:  James V Tricoli; Archie Bleyer
Journal:  Cancer J       Date:  2018 Nov/Dec       Impact factor: 3.360

9.  Quantitative association between body mass index and the risk of cancer: A global Meta-analysis of prospective cohort studies.

Authors:  Xuexian Fang; Jiayu Wei; Xuyan He; Jia Lian; Dan Han; Peng An; Tianhua Zhou; Simin Liu; Fudi Wang; Junxia Min
Journal:  Int J Cancer       Date:  2018-05-13       Impact factor: 7.396

10.  IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.

Authors:  C Houillier; X Wang; G Kaloshi; K Mokhtari; R Guillevin; J Laffaire; S Paris; B Boisselier; A Idbaih; F Laigle-Donadey; K Hoang-Xuan; M Sanson; J-Y Delattre
Journal:  Neurology       Date:  2010-10-26       Impact factor: 11.800

View more
  4 in total

1.  Allopregnanolone Promotes Migration and Invasion of Human Glioblastoma Cells through the Protein Tyrosine Kinase c-Src Activation.

Authors:  Carmen J Zamora-Sánchez; Claudia Bello-Alvarez; Mauricio Rodríguez-Dorantes; Ignacio Camacho-Arroyo
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

2.  Comprehensive Analysis of the Brain-Expressed X-Link Protein Family in Glioblastoma Multiforme.

Authors:  Adilai Aisa; Yinuo Tan; Xinyu Li; Ding Zhang; Yun Shi; Ying Yuan
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

3.  CCL18 Expression Is Higher in a Glioblastoma Multiforme Tumor than in the Peritumoral Area and Causes the Migration of Tumor Cells Sensitized by Hypoxia.

Authors:  Szymon Grochans; Jan Korbecki; Donata Simińska; Wojciech Żwierełło; Sylwia Rzeszotek; Agnieszka Kolasa; Klaudyna Kojder; Maciej Tarnowski; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

Review 4.  The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy.

Authors:  Natalia Simionescu; Radu Zonda; Anca Roxana Petrovici; Adriana Georgescu
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.